作者: Edward A. Mortimer
DOI: 10.1001/JAMA.1977.03270430062023
关键词: Penicillin G Benzathine 、 Group A 、 Medicine 、 Immunology 、 Internal medicine 、 Acute rheumatic fever 、 Streptococcus 、 Recurrent rheumatic fever 、 Heart disease 、 Erythromycin 、 Rheumatic fever
摘要: The American Heart Association has recently published updated recommendations for the prevention of acute rheumatic fever. 1 These are essentially same as those first 24 years ago 2 ; major differences a consequence development injectable penicillin G benzathine and erythromycin, demonstration that group A streptococci frequently exhibit resistance to tetracyclines. similarities indicate there have been very few changes in our approach control heart disease since it was shown fever can be averted by appropriate treatment inciting streptococcal infection recurrent prevented continuous prophylaxis. We still do not know how predict among with infections who at risk fever, distinguish carriers from actual except retrospect, or exactly Streptococcus